In a recent study posted to the bioRxiv* pre-print server, researchers investigated allosteric binders of angiotensin-converting enzyme 2 (ACE2) that significantly inhibit severe acute respiratory ...
In a recent study published in the Cell, researchers assessed the role of angiotensin-converting enzyme 2 (ACE2) in the coronavirus disease 2019 (COVID-19) pandemic. ACE2 is one of the most commonly ...
Continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers before non-cardiac surgery is linked ...
In this rapidly evolving setting, clinicians are weighing the alleged harm of continuing these medications in patients for whom ACE inhibitors and ARBs have known benefit against the harm to their ...
Renin-angiotensin system, or RAS, is a physiological mechanism essential to human body function. The SARS-CoV-2 virus causes overactivation and malfunction of this system. The RAS regulates innate ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Much remains unknown about the novel coronavirus SARS-CoV-2 and the disease it causes, COVID-19, ...
The study by Li et al. involved examining the records of approximately 7.3 million people in the database of the Veterans Health System over a period of 5 years. Patients aged 65 years or older with ...
STOCKHOLM, SE / ACCESS Newswire / September 30, 2025 /Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback